RedixFi
RedixFi

ACUTAAS · Concall Summary

ACUTAAS CHEMICALS LIMITED

Concall2026-07-28
Tone: Positive

Management reported that Acutaas Chemicals Limited began the financial year on a challenging note due to geopolitical tensions but managed to secure raw material availability and maintain supply continuity. The company achieved strong revenue of INR 329.7 crores, reflecting a year-on-year growth of 59.1%. Demand for battery chemicals remained exceptionally strong, with the successful completion of trial runs for the battery chemicals plant. Management highlighted a robust performance in the Advanced Pharmaceutical Intermediates segment, with revenue growth of 76.5%. The Specialty Chemicals segment saw a decline in commodity chemicals revenue, which management anticipated would be offset by growth in battery chemicals and new specialty products. Management set a goal of 25% revenue growth for the full year with stable margins. The earnings call concluded with management expressing confidence in the company's growth trajectory and operational efficiencies.

Management emphasized strong performance and growth opportunities across various segments.

View source filing →

Earlier concalls

  • 2026-07-24The investor presentation from Acutaas Chemicals Limited reported strong financial performance for the first quarter of
  • 2026-05-16The investor presentation from Acutaas Chemicals Limited, dated May 16, 2026, outlines the company's business operations
  • 2026-05-06Acutaas Chemicals Limited held its Q4 FY26 earnings conference call on April 30, 2026, where management provided insight

See ACUTAAS's full Research Pro page — annual report summary, insider trades, promoter pledge trend, options positioning and Ask-RedixFi AI.

Sign up free

Back to ACUTAAS snapshot